Clinical TrialsSearch results
Number of results: 832
Other
- A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
- Type 2 Diabetes
- Masaki Takeshi
- 2023-09-05
Other
- A study to evaluate Patisiran in patients with transthyretin-type amyloidosis with cardiomyopathy (ATTR amyloidosis with cardiomyopathy)
- ATTR amyloidosis with cardiomyopathy
- Alnylam Pharmaceuticals, Inc
- 2021-05-12
Other
- A study to find out whether BI 1015550 improves lung function in people with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
- Progressive Fibrosing Interstitial Lung Diseases
- Yamamoto Akiko
- 2022-11-29
Other
- A study to find out whether BI 1015550 improves lung function in people with Idiopathic Pulmonary Fibrosis (IPF)
- Idiopathic Pulmonary Fibrosis
- Saito Isao
- 2022-09-03
Other
- A study to observe correlation between resection and reconstruction procedures employed for gastric neoplasms and development of postgastrectomy syndrome
- Gastric cancer patients who underwent various types of gastrectomy (GIST patients who underwent gastric wedge resection are also included)
- Department of Surgery, The Jikei University School of Medicine
- 2009-06-25
Other
- A study to test whether BI 456906 helps people living with overweight or obesity who also have diabetes to lose weight
- Obesity
- Ishibashi Yukiko
- 2024-01-10
Other
- A study to test whether BI 456906 helps people living with overweight or obesity who do not have diabetes to lose weight
- Obesity
- Ishibashi Yukiko
- 2024-01-10
Other
- A study to test whether BI 685509 alone or in combination with empagliflozin helps people with liver cirrhosis caused by viral hepatitis or non-alcoholic steatohepatitis (NASH) who have high blood pressure in the portal vein (main vessel going to the liver)
- Patients with CSPH in compensated cirrhosis due to HBV, HCV, and NASH with or without T2DM
- Kutsunai Mitsuru
- 2022-10-14
Other
- A study to test whether BI 685509 helps people with liver cirrhosis and high blood pressure in the portal vein (main vessel going to the liver) who had bleeding in the esophagus or fluid accumulation in the belly
- CSPH in decompensated liver cirrhosis regardless of the etiology of chronic liver disease
- Taguchi Aya
- 2024-01-12
Other
- A study to test whether two different doses of BI 685509 help people with liver cirrhosis and high blood pressure in the portal vein (main vessel going to the liver)
- Patients with CSPH in compensated alcohol-related cirrhosis
- Kutsunai Mitsuru
- 2022-01-28